Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

Rapid Micro Biosystems, Inc. (RPID) vs Talis Biomedical Corporation (TLIS)

Rapid Micro Biosystems, Inc. and Talis Biomedical Corporation are both Medical Devices companies. Rapid Micro Biosystems, Inc. is the larger, with a market value of $55.7M against $46.3M — 1.2× the size. Rapid Micro Biosystems, Inc. grew revenue faster over the last twelve months: 16.1% against −65.2%. Talis Biomedical Corporation has the higher net margin (0.00% vs −145.6%) and the higher return on invested capital (0.00% vs −181.6%). Across the 18 metrics below, Talis Biomedical Corporation leads on 12 and Rapid Micro Biosystems, Inc. on 6.

Valuation

Metric RPID TLIS Medical Devices median
P/E n/m n/m 22.18
P/S 1.53 5.23 2.70
P/B 3.02 0.11 2.46
Price to free cash flow n/m n/m 22.53
EV/EBITDA n/m 1.01 11.78
EV/Sales 1.51 (55.30) 2.38
Earnings yield (100.90%) (986.62%) (8.22%)
Free cash flow yield (75.27%) (775.19%) (7.80%)

Profitability

Metric RPID TLIS Medical Devices median
Gross margin 5.55% 97.27% 56.01%
Operating margin (141.45%) 0.00% (15.03%)
Net margin (145.55%) 0.00% (20.40%)
Free cash flow margin (114.83%) 0.00% (7.24%)
Return on equity (141.65%) (70.48%) (15.32%)
Return on assets (76.40%) (52.13%) (19.72%)
Return on invested capital (181.64%) 0.00% (10.33%)

Growth

Metric RPID TLIS Medical Devices median
Revenue growth (TTM) 16.13% (65.21%) 8.80%
EPS growth (last fiscal year) 2.78% 46.33% —
Revenue growth, 5-year CAGR 15.88% (2.24%) 15.23%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric RPID TLIS Medical Devices median
Debt to equity 1.08 0.00 0.07
Current ratio 2.55 7.76 2.50
Net debt to EBITDA 0.44 1.16 0.49

Dividend

Metric RPID TLIS Medical Devices median
Dividend yield — — 0.94%
Payout ratio 0.00 0.00 0.00

Size

Metric RPID TLIS Medical Devices median
Market cap 55.68m 46.27m 172.91m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack